RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers
Imaging Technology
SEPTEMBER 20, 2023
We are excited, in collaboration with 3BP and others, to advance this molecule through clinical testing to commercialization.” This milestone ushers in a new era of autonomous radiotherapy where the biology of the tumor directs where to deliver the radiation dose. For more information: [link] Wednesday, September 20, 2023 - 09:56
Let's personalize your content